Read a new issue of bi-weekly newsletter with monitoring of Russian activities and influence in Belarus to know more. APRIL 18 - APRIL 28 RECENT POLICY DEVELOPMENTS KREMLIN SIDES WITH BELARUSIAN LEADERSHIP TO EXPOSE AN ALLEGED COUP AGAINST LUKASHENKA On.
Sputnik V May be India s Third Covid Vaccine by Hannah Joy on March 5, 2021 at 11:09 AM
Sputnik V vaccine is one of the world s top three coronavirus vaccines, as the phase III clinical trials of Sputnik V has a strong protective effect across all participant age groups.
To cater to the vaccination process of the world s largest democracy, it would be pertinent to bring in safer and more effective vaccines from other countries. However, on February 24, India s drug authority had asked Dr Reddy s, the Indian pharmaceutical company facilitating the trials in the country, to supply data on immunogenicity for going ahead with the approval process. However, experts across the country have been questioning the approval procedure given the fact that the country gave approval to two homegrown vaccines in January this year for emergency use based on modified standards. For instance, Covaxin was granted restricted approval in clinical trial mode without any efficacy
Two million doses of the Oxford-AstraZeneca Covid-19 vaccine made by the Serum Institute of India arrived in Dhaka on Thursday as a gift from New Delhi. The Air India charter flight 1232 from Mumbai carrying the consignment landed at Shahjalal International Airport in Dhaka at 11.20 a.m. on Thursday. In a tweet, Indian Minister of External Affars S Jaishankar said: Touchdown in Dhaka. #VaccineMaitri reaffirms the highest priority accorded by India to relations with Bangladesh. The vaccines which came as a gift will be handed over at a formal ceremony at State Guesthouse Padma on Thursday afternoon. Bangladesh Foreign Minister AK Abdul Momen, Health Minister Zahid Maleque, State Minister for Foreign Affairs Md Shahriar Alam, High Commissioner of India to Bangladesh Vikram Kumar Doraiswami and other high government officials will be in attendance.
Read more about Dr. Reddys receives DCGI approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India on Business Standard. The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Russia s Health Ministry agreed Wednesday to cut the size of a study of a domestically developed coronavirus vaccine and to stop the enrolment of volunteers. The decision comes a week after developers said enrolment of study volunteers has slowed since Russia began giving out the Sputnik V vaccine while the late-stage study was still continuing. They also cited ethical concerns about giving a dummy shot to some of the volunteers. The study size was cut to about 31,000 from 40,000 participants. Alexander Gintsburg, head of the Gamaleya Center, the state-run medical research institute that developed Sputnik V, said that many of those who received dummy shots had figured it out and gotten vaccinated. If large numbers of volunteers in the placebo group drop out, it could affect the results,